Latest Commercialization News

Boss Energy’s Alta Mesa Uranium Project in Texas is accelerating production with uranium extraction rates surpassing 3,000 pounds per day and ongoing wellfield expansion.

Condor Energy has launched a comprehensive market and commercialisation study for its 1 trillion cubic feet Piedra Redonda gas discovery offshore Peru, aiming to chart a clear path toward development and partnerships.

Argosy Minerals has executed a spot sales contract for 60 tonnes of battery-grade lithium carbonate from its Rincon project, locking in a price tied to the SMM benchmark. This deal underscores the company’s emerging role in the resurging lithium market.

Unibail-Rodamco-Westfield will voluntarily delist from the ASX by late August 2025, citing low liquidity and rising compliance costs. Australian investors holding CHESS Depositary Interests face key decisions on how to manage their holdings.

Carbonxt Group has increased its ownership in the Kentucky activated carbon facility to 43.7%, moving closer to a 50% target as the plant nears commercial production. The company also raised A$1 million via convertible notes to support this strategic expansion.

HyTerra Limited expands its Nemaha Project drilling program by adding a third well, McCoy 1, marking a shift to data-driven site selection. Early gas logs from Blythe 13-20 suggest promising hydrogen and helium presence, pending lab confirmation.

Adherium Limited has announced a partially underwritten entitlement offer aiming to raise approximately A$4.5 million through the issuance of new shares and options at a significant discount. The capital raise is designed to accelerate patient onboarding and product development for its respiratory monitoring technology.

Adherium Limited has successfully closed the institutional portion of its entitlement offer, increasing the raise to $4.492 million due to robust demand. The company now invites retail shareholders to participate as it advances its digital respiratory health solutions.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology monoclonal antibody targeting VISTA, from Hummingbird Bioscience, marking a strategic pivot after recent setbacks. The company plans to initiate phase II trials in 2026, aiming to advance this novel cancer therapy toward commercialisation.

Carnegie Clean Energy has secured $335,020 in funding from the Blue Economy CRC to progress the preliminary design of its MoorPower commercial pilot, aiming to revolutionize offshore aquaculture energy use.

Neometals’ joint venture Reed Advanced Materials has signed a non-binding MoU with Rio Tinto to collaborate on advancing the ELi Process, a lithium hydroxide production technology promising significant cost and environmental benefits.

xReality Group has raised $2 million through a discounted share placement to fuel the international expansion of its Operator XR virtual reality training platform, targeting law enforcement and military sectors.